VBI Vaccines Inc.
A biopharmaceutical company that develops and commercializes vaccines and immunotherapies for the prevention and treatment of infectious diseases and cancer. In addition to developing, manufacturing, and selling a vaccine for hepatitis B, the company develops preventive vaccines for cytomegalovirus infection, COVID-19, etc., as well as immunotherapies for hepatitis B and glioblastoma.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 131 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 22.57M |
Revenue | 9.41M |
Operating Income | -72.16M |
Operating Margin | -766.73% |
Net Income | -83.99M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4636 / 5373 |
Sector : Healthcare | 803 / 1144 |
Industry : Biotechnology | 383 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4913 / 5565 |
Sector : Healthcare | 938 / 1182 |
Industry : Biotechnology | 523 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4655 / 5436 |
Sector : Healthcare | 861 / 1164 |
Industry : Biotechnology | 439 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3833 / 5330 |
Sector : Healthcare | 561 / 1174 |
Industry : Biotechnology | 204 / 667 |